Symptoms During A Gastric Emptying Study
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 17-004008
Sponsor Protocol Number: 17-004008
About this study
To understand the utility of measuring stomach emptying, symptoms during a stomach emptying, and blood markers of body metabolism.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Male or female patients aged 18 years and older undergoing a clinically indicated gastric emptying study, with or without an assessment of small intestinal and colonic transi
- Symptoms of dyspepsia (i.e., early satiety, postprandial discomfort, nausea, vomiting, regurgitation)
- Able to provide written informed consent before participating in the study
- Able to communicate adequately with the investigator and to comply with the requirements for the entire study
Exclusion Criteria:
- Clinical evidence of significant cardiovascular, respiratory, renal, hepatic, gastrointestinal, hematological, neurological, psychiatric or other disease that may interfere with the objectives of the study
- Medications. Opiates, metoclopramide, and high doses of anticholinergic agents (eg, amitriptyline greater than 50 mg daily)
- Treatment with GLP-1 agonists and amlyin which cause vagal blockade and may affect central processing of pain
- Any other condition or prior therapy that, in the opinion of the investigator, would make the patient unsuitable for the study
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
More information
Publications
Publications are currently not available